Cancer Medicine Исследования рака

Efficacy and Safety of Datopotamab Deruxtecan From a Single‐Institution Experience in Hormone Receptor–Positive, HER2‐Negative Metastatic Breast Cancer After Multiple Prior Therapies Including Antibody–Drug Conjugates

Hiroko Shimada, Maki Todo, Hiroshi Ishiguro, Emi Mikami, Wakako Inohana, Taeko Kurosawa, Ayako Nakame, Ayaka Sakakibara, Yuki Ichinose, Akihiro Fujimoto, Asami Nukui, Aya Asano, Hideki Yokogawa, Masahiro Ohara, Kazuo Matsuura, Takahiro Hasebe, Nobuko Fujiuchi, Akihiko Osaki, Toshiaki Saeki
Wiley · 2026-11-07 · DOI 10.1002/cam4.72457
⬢ Цитируемость: 0 Crossref

Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.

Читать у издателя →